Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA) Forecast

    Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA) Forecast
    Date: 07 Feb, 2017              Type: Diagnostics              Pages: 238

    • Electronic Access - Single User License
      $1,990.00
    • CD-ROM Mail Delivery
      $2,090.00
    • Hard-copy Mail Delivery
      $2,190.00
    • Electronic Access - Multi User License
      $2,800.00

    Get Free 10% Customization in This Report

    Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA) Forecast is a 238 page market research report with 245 Figures and 15 Tables. Global Cervical Market is expected to be close to US$ 7 Billion by 2020. North America controls almost 50 percent Cervical Cancer Market. United States and Japan together makes more than 50 percent market share. In Europe region, United Kingdom and France are other top two leading countries in this market place. Asia has highest share in cervical cancer screening population. Indonesia, China and India are top three countries having largest cervical cancer test population in Asia. In the study we have found that Japan market will steadily decline over forecast period.

    The report published by Renub Research provides a complete analysis of top 20 Countries Cervical Cancer Test 1) Market, 2)Population & 3)Mortality

    These 3 points have been further sub divided into following segments.

    1.    Cervical Cancer Test Market (2008 – 2020)

    •    Pap Smear Test Market (2008 – 2020)
    •    HPV DNA Test Market (2008 – 2020)
    •    VIA Test Market (2008 – 2020)

    2.    Cervical cancer Test Population (2008 – 2020)

    •    Pap Smear Test Population (2008 – 2020)
    •    HPV DNA Test Population (2008 – 2020)
    •    VIA Test Population (2008 – 2020)

    3.    Cervical Cancer Mortality Population (2001 – 2011)

     

    All the 20 Countries Studied in the Report are as Follows

    1.    United Kingdom
    2.    France
    3.    Germany
    4.    Italy
    5.    Spain
    6.    Sweden
    7.    Switzerland
    8.    Norway
    9.    Netherlands
    10.    United States
    11.    Canada
    12.    Japan
    13.    Korea
    14.    Singapore
    15.    Malaysia
    16.    Australia
    17.    India
    18.    China
    19.    Thailand
    20.    Indonesia

     

    Key Questions Answered in the Report?

    • What is Global Cervical Cancer Screening Market, Forecast and by Countries??
    • What is Global Pap Smear Screening Market and by Countries?
    • What is Global HPV DNA Screening Market, Forecast and by Countries??
    • What is Global Visual Inspection with Acetic Acid (VIA) Screening Market, Forecast and by Countries?
    • What is Cervical Cancer Screening Market in Asia, Europe and North America?
    • What is Cervical Cancer Screening Population in North America, Asia and Europe?

     

    1.    Executive Summary

    2.    Global Cervical Cancer Test (Screening) Population & Forecast
    2.1    Asia Cervical Cancer Test (Screening) Population & Forecast

    2.2    Europe Cervical Cancer Test (Screening) Population & Forecast

    2.3    North America Cervical Cancer Test (Screening) Population & Forecast

    3.    Global Cervical Cancer Test (Screening) Market & Forecast
    3.1    Global Cervical Cancer Pap Smear Test (Screening) Market & Forecast

    3.2    Global Cervical Cancer HPV DNA Test (Screening) Market & Forecast

    3.3    Global - Cervical Cancer Visual Inspection with Acetic Acid (VIA) Test (Screening) Market & Forecast

    4.    By Region – Global Cervical Cancer Test (Screening) Market Analysis
    4.1    Asia Cervical Cancer Test (Screening) Market & Forecast

    4.2    Europe Cervical Cancer Test (Screening) Market & Forecast

    4.3    North America Cervical Cancer Test (Screening) Market & Forecast

    5.    Global Cervical Cancer Test (Screening) Population Share & Forecast
    5.1    By Region – Global Cervical Cancer Test (Screening) Population Share & Forecast

    5.2    By Countries – Global Cervical Cancer Test (Screening) Population Country Share & Forecast

    6.    Global Cervical Cancer Test (Screening) Market Share & Forecast
    6.1    By Region – Global Cervical Cancer Test (Screening) Market Share & Forecast

    6.2    By Countries – Global Cervical Cancer Test (Screening) Market Share & Forecast

    6.3    By Countries – Global Pap Smear Test (Screening) Market Share & Forecast

    6.4    By Countries – Global HPV DNA Test (Screening) Market Share & Forecast

    6.5    By Countries – Global VIA Test (Screening) Market Share & Forecast

    7.    United Kingdom – Cervical Cancer Test Analysis
    7.1    United Kingdom Cervical Cancer Test (Screening) Population
    7.1.1    United Kingdom Cervical Cancer Pap Smear Test Population & Forecast
    7.1.2    United Kingdom Cervical Cancer HPV DNA Test Population & Forecast

    7.2    United Kingdom Cervical Cancer Deaths

    7.3    United Kingdom Cervical Cancer Test (Screening) Analysis
    7.3.1    United Kingdom Cervical Cancer Test Market & Forecast
    7.3.2    United Kingdom Pap Smear Test Market & Forecast
    7.3.3    United Kingdom HPV DNA Test Market & Forecast

    8.    France – Cervical Cancer Test Analysis
    8.1    France Cervical Cancer Test (Screening) Population
    8.1.1    France Cervical Cancer Pap Smear Test Population & Forecast
    8.1.2    France Cervical Cancer HPV DNA Test Population & Forecast

    8.2    France Cervical Cancer Mortality

    8.3    France Cervical Cancer Test (Screening) Analysis
    8.3.1    France Cervical Cancer Test Market & Forecast
    8.3.2    France Pap Smear Test Market & Forecast
    8.3.3    France HPV DNA Test Market & Forecast

    9.    Germany – Cervical Cancer Test Analysis
    9.1    Germany Cervical Cancer Test (Screening) Population
    9.1.1    Germany Cervical Cancer Pap Smear Test Population & Forecast
    9.1.2    Germany Cervical Cancer HPV DNA Test Population & Forecast

    9.2    Germany Cervical Cancer Mortality

    9.3    Germany Cervical Cancer Test (Screening) Market
    9.3.1    Germany Cervical Cancer Test Market & Forecast
    9.3.2    Germany Pap Smear Test Market & Forecast
    9.3.3    Germany HPV DNA Test Market & Forecast

    10.    Italy – Cervical Cancer Test Analysis
    10.1    Italy Cervical Cancer Test (Screening) Population
    10.1.1    Italy Cervical Cancer Pap Smear Test Population & Forecast
    10.1.2    Italy Cervical Cancer HPV DNA Test Population & Forecast

    10.2    Italy Cervical Cancer Mortality

    10.3    Italy Cervical Cancer Test (Screening) Market
    10.3.1    Italy Cervical Cancer Test Market & Forecast
    10.3.2    Italy Pap Smear Test Market & Forecast
    10.3.3    Italy HPV DNA Test Market & Forecast

    11.    Spain – Cervical Cancer Test Analysis
    11.1    Spain Cervical Cancer Test (Screening) Population
    11.1.1    Spain Cervical Cancer Pap Smear Test Population & Forecast
    11.1.2    Spain Cervical Cancer HPV DNA Test Population & Forecast

    11.2    Spain Cervical Cancer Mortality

    11.3    Spain Cervical Cancer Test (Screening) Market
    11.3.1    Spain Cervical Cancer Test Market & Forecast
    11.3.2    Spain Pap Smear Test Market & Forecast
    11.3.3    Spain HPV DNA Test Market & Forecast

    12.    Sweden – Cervical Cancer Test Analysis
    12.1    Sweden Cervical Cancer Test (Screening) Population
    12.1.1    Sweden Cervical Cancer Pap Smear Test Population & Forecast
    12.1.2    Sweden Cervical Cancer HPV DNA Test Population & Forecast

    12.2    Sweden Cervical Cancer Mortality

    12.3    Sweden Cervical Cancer Test (Screening) Market
    12.3.1    Sweden Cervical Cancer Test Market & Forecast
    12.3.2    Sweden Pap Smear Test Market & Forecast
    12.3.3    Sweden HPV DNA Test Market & Forecast

    13.    Switzerland – Cervical Cancer Test Analysis
    13.1    Switzerland Cervical Cancer Test (Screening) Population
    13.1.1    Switzerland Cervical Cancer Pap Smear Test Population & Forecast
    13.1.2    Switzerland Cervical Cancer HPV DNA Test Population & Forecast

    13.2    Switzerland Cervical Cancer Mortality

    13.3    Switzerland Cervical Cancer Test (Screening) Market
    13.3.1    Switzerland Cervical Cancer Test Market & Forecast
    13.3.2    Switzerland Pap Smear Test Market & Forecast
    13.3.3    Switzerland HPV DNA Test Market & Forecast

    14.    Norway – Cervical Cancer Test Analysis
    14.1    Norway Cervical Cancer Test (Screening) Population
    14.1.1    Norway Cervical Cancer Pap Smear Test Population & Forecast
    14.1.2    Norway Cervical Cancer HPV DNA Test Population & Forecast

    14.2    Norway Cervical Cancer Mortality

    14.3    Norway Cervical Cancer Test (Screening) Market
    14.3.1    Norway Cervical Cancer Test Market & Forecast
    14.3.2    Norway Pap Smear Test Market & Forecast
    14.3.3    Norway HPV DNA Test Market & Forecast

    15.    Netherlands – Cervical Cancer Test Analysis
    15.1    Netherlands Cervical Cancer Test (Screening) Population
    15.1.1    Netherlands Cervical Cancer Pap Smear Test Population & Forecast
    15.1.2    Netherlands Cervical Cancer HPV DNA Test Population & Forecast

    15.2    Netherlands Cervical Cancer Mortality

    15.3    Netherlands Cervical Cancer Test (Screening) Market
    15.3.1    Netherlands Cervical Cancer Test Market & Forecast
    15.3.2    Netherlands Pap Smear Test Market & Forecast
    15.3.3    Netherlands HPV DNA Test Market & Forecast

    16.    United States – Cervical Cancer Test Analysis
    16.1    United States Cervical Cancer Test (Screening) Population
    16.1.1    United States Cervical Cancer Pap Smear Test Population & Forecast
    16.1.2    United States Cervical Cancer HPV DNA Test Population & Forecast

    16.2    United States Cervical Cancer Mortality

    16.3    United States Cervical Cancer Test (Screening) Market
    16.3.1    United States Cervical Cancer Test Market & Forecast
    16.3.2    United States Pap Smear Test Market & Forecast
    16.3.3    United States HPV DNA Test Market & Forecast

    17.    Canada – Cervical Cancer Test Analysis
    17.1    Canada Cervical Cancer Test (Screening) Population
    17.1.1    Canada Cervical Cancer Pap Smear Test Population & Forecast
    17.1.2    Canada Cervical Cancer HPV DNA Test Population & Forecast

    17.2    Canada Cervical Cancer Mortality

    17.3    Canada Cervical Cancer Test (Screening) Market
    17.3.1    Canada Cervical Cancer Test Market & Forecast
    17.3.2    Canada Pap Smear Test Market & Forecast
    17.3.3    Canada HPV DNA Test Market & Forecast

    18.    Japan – Cervical Cancer Test Analysis
    18.1    Japan Cervical Cancer Test (Screening) Population
    18.1.1    Japan Cervical Cancer Pap Smear Test Population & Forecast
    18.1.2    Japan Cervical Cancer HPV DNA Test Population & Forecast

    18.2    Japan Cervical Cancer Mortality

    18.3    Japan Cervical Cancer Test (Screening) Market
    18.3.1    Japan Cervical Cancer Test Market & Forecast
    18.3.2    Japan Pap Smear Test Market & Forecast
    18.3.3    Japan HPV DNA Test Market & Forecast

    19.    South Korea – Cervical Cancer Tests Analysis
    19.1    South Korea - Cervical Cancer Test (Screening) Population
    19.1.1    South Korea - Cervical Cancer Pap Smear Test Population & Forecast
    19.1.2    Korea Cervical Cancer HPV DNA Test Population & Forecast

    19.2    Korea Cervical Cancer Mortality

    19.3    Korea Cervical Cancer Test (Screening) Market
    19.3.1    Korea Cervical Cancer Test Market & Forecast
    19.3.2    Korea Pap Smear Test Market & Forecast
    19.3.3    Korea HPV DNA Test Market & Forecast

    20.    Singapore – Cervical Cancer Tests Analysis
    20.1    Singapore - Cervical Cancer Test (Screening) Population
    20.1.1    Singapore - Cervical Cancer Pap Smear Test Population & Forecast
    20.1.2    Singapore Cervical Cancer HPV DNA Test Population & Forecast

    20.2    Singapore Cervical Cancer Test (Screening) Market
    20.2.1    Singapore Cervical Cancer Test Market & Forecast
    20.2.2    Singapore Pap Smear Test Market & Forecast
    20.2.3    Singapore HPV DNA Test Market & Forecast

    21.    Malaysia – Cervical Cancer Test Analysis
    21.1    Malaysia - Cervical Cancer Test (Screening) Population
    21.1.1    Malaysia Cervical Cancer Pap Smear Test Population & Forecast
    21.1.2    Malaysia Cervical Cancer HPV DNA Test Population & Forecast

    21.2    Malaysia Cervical Cancer Test (Screening) Market
    21.2.1    Malaysia Cervical Cancer Test Market & Forecast
    21.2.2    Malaysia Pap Smear Test Market & Forecast
    21.2.3    Malaysia HPV DNA Test Market & Forecast

    22.    India – Cervical Cancer Test Analysis
    22.1    India - Cervical Cancer Test (Screening) Population
    22.1.1    India Cervical Cancer Pap Smear Test Population & Forecast
    22.1.2    India Cervical Cancer HPV DNA Test Population & Forecast
    22.1.3    India Cervical Cancer VIA Test Population & Forecast

    22.2    India Cervical Cancer Test (Screening) Market
    22.2.1    India Cervical Cancer Test Market & Forecast
    22.2.2    India Pap Smear Test Market & Forecast
    22.2.3    India HPV DNA Test Market & Forecast
    22.2.4    India VIA Test Market & Forecast

    23.    China – Cervical Cancer Test Analysis
    23.1    China - Cervical Cancer Test (Screening) Population
    23.1.1    China Cervical Cancer Pap smear Test Population & Forecast
    23.1.2    China Cervical Cancer HPV DNA Test Population & Forecast
    23.1.3    China Cervical Cancer VIA Test Population & Forecast

    23.2    China - Cervical Cancer Test (Screening) Market
    23.2.1    China Cervical Cancer Test Market & Forecast
    23.2.2    China Pap Smear Test Market & Forecast
    23.2.3    China HPV DNA Test Market & Forecast
    23.2.4    China VIA Test Market & Forecast

    24.    Thailand – Cervical Cancer Test Analysis
    24.1    Thailand - Cervical Cancer Test (Screening) Population
    24.1.1    Thailand Cervical Cancer Pap Smear Test Population & Forecast
    24.1.2    Thailand Cervical Cancer VIA Test Population & Forecast

    24.2    Thailand Cervical Cancer Test (Screening) Market
    24.2.1    Thailand Cervical Cancer Test Market & Forecast
    24.2.2    Thailand Pap smear Test Market & Forecast
    24.2.3    Thailand VIA Test Market & Forecast

    25.    Indonesia – Cervical Cancer Test Analysis
    25.1    Indonesia Cervical Cancer Test (Screening) Population
    25.1.1    Indonesia Cervical Cancer Pap Smear Test Population & Forecast
    25.1.2    Indonesia Cervical Cancer HPV DNA Test Population & Forecast
    25.1.3    Indonesia Cervical Cancer VIA Test Population & Forecast
    25.1.4    Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Population & Forecast

    25.2    Indonesia Cervical Cancer Test (Screening) Market
    25.2.1    Indonesia Cervical Cancer Test Market & Forecast
    25.2.2    Indonesia Pap smear Test Market & Forecast
    25.2.3    Indonesia HPV DNA Test Market & Forecast
    25.2.4    Indonesia VIA Test Market & Forecast
    25.2.5    Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Market & Forecast

    26.    Cervical Cancer Test Market Growth Drivers
    26.1    Introduction of Low Cost VIA Test
    26.1.1    Countries Offering VIA Test via National Programs
    26.1.2    Countries Offering VIA Test via Pilot Programs

    26.2    Worldwide High Prevalence of HPV Infected Patients

    26.3    Rising Number of Incidence of Cervical Cancer in United Kingdom

    26.4    Worldwide Rising Incidence of Teenage Sexual Cases

    27.    Challenges in Cervical Cancer Test Market
    27.1    Lack of Appropriate Healthcare Infrastructure

    27.2    Introduction of HPV Vaccination Programs Worldwide

    List of Figures:

    Figure 2 1: Global – Cervical Cancer Test Population (Million), 2008 – 2015
    Figure 2 2: Global – Forecast for Cervical Cancer Test Population (Million), 2016 – 2020
    Figure 2 3: Asia – Cervical Cancer Test Population (Million), 2008 – 2015
    Figure 2 4: Asia – Forecast for Cervical Cancer Test Population (Million), 2016 – 2020
    Figure 2 5: Europe – Cervical Cancer Test Population (Million), 2008 – 2015
    Figure 2 6: Europe – Forecast for Cervical Cancer Test Population (Million), 2016 – 2020
    Figure 2 7: North America – Cervical Cancer Test Population (Million), 2008 – 2015
    Figure 2 8: North America – Forecast for Cervical Cancer Test Population (Million), 2016 – 2020

    Figure 3 1: Global – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 3 2: Global – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 3 3: Global – Cervical Cancer Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 3 4: Global – Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 3 5: Global – Cervical Cancer HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 3 6: Global – Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2016 – 2020
    Figure 3 7: Global – Cervical Cancer VIA Test Market (Million US$), 2008 – 2015
    Figure 3 8: Global – Forecast for Cervical Cancer VIA Test Market (Million US$), 2016 – 2020

    Figure 4 1: Asia – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 4 2: Asia – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 4 3: Europe – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 4 4: Europe – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 4 5: North America – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 4 6: North America – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020

    Figure 5 1: Global - Cervical Cancer Test (Screening) Population Share (Percent) by Region, 2008 – 2015
    Figure 5 2: Global – Forecast for Cervical Cancer Test (Screening) Population Share (Percent) by Region, 2016 – 2020

    Figure 6 1: Global – Cervical Cancer Market Share (Percent) By Region, 2008 – 2015
    Figure 6 2: Global – Forecast for Cervical Cancer Market Share (Percent) By Region, 2016 – 2020

    Figure 7 1: United Kingdom – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 7 2: United Kingdom – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 7 3: United Kingdom – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 7 4: United Kingdom – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 7 5: United Kingdom – Cervical Cancer Deaths (Number), 2001 – 2011
    Figure 7 6: United Kingdom – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 7 7: United Kingdom – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 7 8: United Kingdom – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 7 9: United Kingdom – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 7 10: United Kingdom – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 7 11: United Kingdom – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 8 1: France – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 8 2: France – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 8 3: France – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 8 4: France – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 8 5: France – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 8 6: France – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 8 7: France – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 8 8: France – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 8 9: France – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 8 10: France – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 8 11: France – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 9 1: Germany – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 9 2: Germany – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 9 3: Germany – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013
    Figure 9 4: Germany – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020
    Figure 9 5: Germany – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 9 6: Germany – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 9 7: Germany – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 9 8: Germany – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 9 9: Germany – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 9 10: Germany – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 9 11: Germany – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 10 1: Italy – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 10 2: Italy – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 10 3: Italy – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 10 4: Italy – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 10 5: Italy – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 10 6: Italy – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 10 7: Italy – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 10 8: Italy – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 10 9: Italy – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 10 10: Italy – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 10 11: Italy – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 11 1: Spain – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 11 2: Spain – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 11 3: Spain – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 11 4: Spain – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 –2020
    Figure 11 5: Spain – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 11 6: Spain – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 11 7: Spain – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 11 8: Spain – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 11 9: Spain – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 11 10: Spain – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 11 11: Spain – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 12 1: Sweden – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 12 2: Sweden – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 12 3: Sweden – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 12 4: Sweden – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 12 5: Sweden – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 12 6: Sweden – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 12 7: Sweden – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 12 8: Sweden – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 12 9: Sweden – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 12 10: Sweden – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 12 11: Sweden – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 13 1: Switzerland – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 13 2: Switzerland – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 13 3: Switzerland – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 13 4: Switzerland – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 13 5: Switzerland – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 13 6: Switzerland – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 13 7: Switzerland – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 13 8: Switzerland – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 13 9: Switzerland – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 13 10: Switzerland – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 13 11: Switzerland – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 14 1: Norway – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 14 2: Norway – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 14 3: Norway – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 14 4: Norway – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 14 5: Norway – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 14 6: Norway – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 14 7: Norway – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 14 8: Norway – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 14 9: Norway – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 14 10: Norway – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 14 11: Norway – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 15 1: Netherlands – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 15 2: Netherlands – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 15 3: Netherlands – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 15 4: Netherlands – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 15 5: Netherlands – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 15 6: Netherlands – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 15 7: Netherlands – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 15 8: Netherlands – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 15 9: Netherlands – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 15 10: Netherlands – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 15 11: Netherlands – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 16 1: United States – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 16 2: United States – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 16 3: United States – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 16 4: United States – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 16 5: United States – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 16 6: United States – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 16 7: United States – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 16 8: United States – Pap smear Test Market (Million US$), 2008 – 2015
    Figure 16 9: United States – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 16 10: United States – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 16 11: United States – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 17 1: Canada – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 17 2: Canada – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 17 3: Canada – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 17 4: Canada – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 17 5: Canada – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 17 6: Canada – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 17 7: Canada – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 17 8: Canada – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 17 9: Canada – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 17 10: Canada – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 17 11: Canada – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 18 1: Japan – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 18 2: Japan – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 18 3: Japan – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 18 4: Japan – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 18 5: Japan – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 18 6: Japan – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 18 7: Japan – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 18 8: Japan – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 18 9: Japan – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 18 10: Japan – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 18 11: Japan – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 19 1: Korea – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 19 2: Korea – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 19 3: Korea – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 19 4: Korea – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 19 5: Korea – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 19 6: Korea – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 19 7: Korea – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 19 8: Korea – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 19 9: Korea – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 19 10: Korea – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 19 11: Korea – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 20 1: Singapore – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 20 2: Singapore – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 20 3: Singapore – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 20 4: Singapore – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 20 5: Singapore – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 20 6: Singapore – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 20 7: Singapore – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 20 8: Singapore – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 20 9: Singapore – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 20 10: Singapore – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 21 1: Malaysia – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 21 2: Malaysia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 21 3: Malaysia – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 21 4: Malaysia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 21 5: Malaysia – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 21 6: Malaysia – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 21 7: Malaysia – Pap smear Test Market (Million US$), 2008 – 2015
    Figure 21 8: Malaysia – Forecast for Pap smear Test Market (Million US$), 2016 – 2020
    Figure 21 9: Malaysia – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 21 10: Malaysia – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 22 1: India – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 22 2: India – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 22 3: India – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 22 4: India – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 22 5: India – Cervical Cancer VIA Test Population (Thousand), 2008 – 2015
    Figure 22 6: India – Forecast for Cervical Cancer VIA Test Population (Thousand), 2016 – 2020
    Figure 22 7: India – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 22 8: India – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 22 9: India – Pap smear Test Market (Million US$), 2008 – 2015
    Figure 22 10: India – Forecast for Pap smear Test Market (Million US$), 2016 – 2020
    Figure 22 11: India – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 22 12: India – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
    Figure 22 13: India – VIA Test Market (Million US$), 2008 – 2015
    Figure 22 14: India – Forecast for VIA Test Market (Million US$), 2016 – 2020

    Figure 23 1: China – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 23 2: China – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 23 3: China – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 23 4: China – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 23 5: China – Cervical Cancer VIA Test Population (Thousand), 2008 – 2015
    Figure 23 6: China – Forecast for Cervical Cancer VIA Test Population (Thousand), 2016 – 2020
    Figure 23 7: China – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 23 8: China – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 23 9: China – Pap smear Test Market (Million US$), 2008 – 2015
    Figure 23 10: China – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 23 11: China – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 23 12: China – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
    Figure 23 13: China – VIA Test Market (Million US$), 2008 – 2015
    Figure 23 14: China – Forecast for VIA Test Market (Million US$), 2016 – 2020

    Figure 24 1: Thailand – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 24 2: Thailand – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 24 3: Thailand – Cervical Cancer VIA Test Population (Thousand), 2008 – 2015
    Figure 24 4: Thailand – Forecast for Cervical Cancer VIA Test Population (Thousand), 2016 – 2020
    Figure 24 5: Thailand – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 24 6: Thailand – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 24 7: Thailand – Pap smear Test Market (Million US$), 2008 – 2015
    Figure 24 8: Thailand – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 24 9: Thailand – VIA Test Market (Million US$), 2008 – 2015
    Figure 24 10: Thailand – Forecast for VIA Test Market (Million US$), 2016 – 2020

    Figure 25 1: Indonesia – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 25 2: Indonesia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 25 3: Indonesia – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 25 4: Indonesia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 25 5: Indonesia – Cervical Cancer VIA Test Population (Thousand), 2008 – 2015
    Figure 25 6: Indonesia – Forecast for Cervical Cancer VIA Test Population (Thousand), 2016 – 2020
    Figure 25 7: Indonesia – Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2008 – 2015
    Figure 25 8: Indonesia – Forecast for Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2016 – 2020
    Figure 25 9: Indonesia – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 25 10: Indonesia – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 25 11: Indonesia – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 25 12: Indonesia – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 25 13: Indonesia – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 25 14: Indonesia – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
    Figure 25 15: Indonesia – VIA Test Market (Million US$), 2008 – 2015
    Figure 25 16: Indonesia – Forecast for VIA Test Market (Million US$), 2016 – 2020
    Figure 25 17: Indonesia – Both (Pap smear & VIA) Test Market (Million US$), 2008 – 2015
    Figure 25 18: Indonesia – Forecast for Both (Pap Smear & VIA) Test Market (Million US$), 2016 – 2020

     

    List of Tables:

    Table 5 1: Global –Cervical Cancer Test Population Share (Percent) By Country, 2008 – 2015
    Table 5 2: Global – Forecast for Cervical Cancer Test Population Share (Percent) by Country, 2016 – 2020

    Table 6 1: Global – Cervical Cancer Test Market Share (Percent) by Country, 2008 – 2015
    Table 6 2: Global – Forecast for Cervical Cancer Test Market Share (Percent) by Country, 2016 – 2020
    Table 6 3: Global – Pap Smear Test Market Share (Percent), 2008 – 2015
    Table 6 4: Global – Forecast for Pap Smear Test Market Share (Percent), 2016 – 2020
    Table 6 5: Global – HPV DNA Test Market Share (Percent), 2008 – 2015
    Table 6 6: Global – Forecast for HPV DNA Test Market Share (Percent), 2016 – 2020
    Table 6 7: Global – VIA Test Market Share (Percent), 2008 – 2015
    Table 6 8: Global – Forecast for VIA Test Market Share (Percent), 2016 – 2020

    Table 26 1: Worldwide – List of Countries which offer VIA Test via National Programs, 2015
    Table 26 2: Worldwide – List of Countries which offer VIA Test via Pilot Programs, 2015
    Table 26 3: Worldwide – Prevalence of HPV 16/18 in Women with Normal Cervical Cytology (Percent), 2014 - 2015
    Table 26 4: United Kingdom – Number of Incidence Observed and Projected and their respective Age Standardized Rate, 2010 - 2025
    Table 26 5: Worldwide – Prevalence (Percent) of Young Women (15–44 Years) who Have Sex before the Age of 15 Years, 1994 – 2006

     


    Related Products